Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 394

    Senate reauthorizes FDA to collect fees from drugmakers

    Senate reauthorizes FDA to collect fees from drugmakers

    Ruby Khatun Khatun8 Aug 2017 9:15 AM IST
    The U.S. Senate on Thursday passed a bill allowing the Food and Drug Administration to continue collecting fees from drug companies to review new...
    FDA approves Imbruvica to treat chronic graft versus host disease

    FDA approves Imbruvica to treat chronic graft versus host disease

    Ruby Khatun Khatun7 Aug 2017 9:30 AM IST
    The U.S. Food and Drug Administration (FDA) expanded the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft...
    hCue joins hand with CAMS to Help Pharmacy Retailers and Distributors Across India

    hCue joins hand with CAMS to Help Pharmacy Retailers and Distributors Across India

    Ruby Khatun Khatun7 Aug 2017 9:19 AM IST
    Chennai: CAMS (Computer Age Management Services), a leading and integral part of Indian financial infrastructure co-owned by NSE Strategic Investment...
    FDA panel votes against approval of J&J arthritis drug

    FDA panel votes against approval of J&J arthritis drug

    Ruby Khatun Khatun7 Aug 2017 9:18 AM IST
    The benefits of Johnson & Johnson's experimental rheumatoid arthritis drug sirukumab do not outweigh the risks, an advisory panel to the U.S. Food...
    Eli Lilly acute migraine drug succeeds in late-stage study

    Eli Lilly acute migraine drug succeeds in late-stage study

    Ruby Khatun Khatun7 Aug 2017 9:18 AM IST
    Drugmaker Eli Lilly and Co said on Friday its acute migraine drug lasmiditan succeeded in a key late-stage study, setting the stage for U.S....
    Pharma stocks under pressure, fall up to 5 percent

    Pharma stocks under pressure, fall up to 5 percent

    Ruby Khatun Khatun7 Aug 2017 9:16 AM IST
    New Delhi: Pharma stocks were under selling pressure, falling up to 5 per cent, led by Biocon and Dr Reddy's Lab.Shares of Morepen Laboratories fell...
    Regeneron beats profit view, to end antibody deal with Sanofi

    Regeneron beats profit view, to end antibody deal with Sanofi

    Ruby Khatun Khatun7 Aug 2017 9:15 AM IST
    Regeneron Pharmaceuticals Inc reported a much better-than-expected quarterly profit on strong demand for its flagship Eylea drug and said it would end...
    European Patent Office to Grant Mercks Patent Application for CRISPR Technology

    European Patent Office to Grant Merck's Patent Application for CRISPR Technology

    Ruby Khatun Khatun6 Aug 2017 9:30 AM IST
    DARMSTADT, Germany: Merck, a leading science and technology company, announced the European Patent Office (EPO) has issued a "Notice of Intention to...
    Punjab to examine feasibility of new drug for Hepatitis-C

    Punjab to examine feasibility of new drug for Hepatitis-C

    Ruby Khatun Khatun6 Aug 2017 9:30 AM IST
    Chandigarh: Punjab Chief Minister Captain Amarinder Singh asked the health department to examine the feasibility of a new drug Epclusa for treatment...
    Big Pharma plans to turn rural India into a cash cow

    Big Pharma plans to turn rural India into a cash cow

    Ruby Khatun Khatun6 Aug 2017 9:20 AM IST
    By Ari AltstedterFirst, foreign food brands flooded India with chips, cookies and soft drinks that fundamentally changed the nation’s eating habits....
    Bristol-Myers Squibb and Clovis Oncology Announce a Broad Clinical Collaboration

    Bristol-Myers Squibb and Clovis Oncology Announce a Broad Clinical Collaboration

    Ruby Khatun Khatun6 Aug 2017 9:16 AM IST
    New York & Boulder, Colo.: Bristol-Myers Squibb Company and Clovis Oncology, Inc. announced the companies have entered into a clinical...
    USFDA to review Teva and Celltrions cancer biosimilar drug

    USFDA to review Teva and Celltrion's cancer biosimilar drug

    Ruby Khatun Khatun6 Aug 2017 9:15 AM IST
    JERUSALEM: Teva Pharmaceutical Industries and South Korea's Celltrion said the U.S. Food and Drug Administration has accepted for review a biologics...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok